(Q40145570)

17 September 2017

1 reference

title

New penicillins and their use in pediatrics (English)

1 reference

17 September 2017

New Penicillins and Their Use in Pediatrics (English)

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34315-2

2 October 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338467

2 October 2023

author name string

A. S. Prince

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338467

2 October 2023

H. C. Neu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6338467

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6338467

2 October 2023

publication date

1 February 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0031395516343152?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34315-2

https://api.elsevier.com/content/article/PII:S0031395516343152?httpAccept=text/plain

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34315-2

Pediatric Clinics of North America

2 October 2023

published in

1 reference

17 September 2017

volume

30

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

3-16

1 reference

Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Kinetics of intravenous mezlocillin in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Azlocillin and mezlocillin: new ureido penicillins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Comparative pharmacokinetics of cyclacillin and amoxicillin in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Double-Blind Clinical Trials of Oral Cyclacillin and Ampicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Physiological properties of penicillin-binding proteins in group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Serum and urinary concentrations of cyclacillin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Clinical experience with meziodilin in Europe--overview

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Susceptibility of the Anaerobic Bacteria, Group D Streptococci, Enterobacteriaceae , and Pseudomonas to Semisynthetic Penicillins: Carbenicillin, Piperacillin, and Ticarcillin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

The pharmacokinetics of bacampicillin.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Comparative Studies of Penicillin-Binding Proteins in Pseudomonas aeruginosa and Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

The safety and tolerance of mezlocillin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Clinical pharmacology and efficacy of mezlocillin in paediatric patients with malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Pharmacokinetic studies of mezlocillin in newborn infants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Properties of the Penicillin-Binding Proteins of Escherichia coli K12

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Cyclacillin: microbiological and pharmacological properties and use in chemotherapy of infection - a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

In vivo interaction of beta-lactam antibiotics with the penicillin-binding proteins of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Piperacillin therapy for serious bacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2934315-2

7 January 2021

Pharmacokinetics of azlocillin in children with cystic fibrosis

series ordinal

1

1 reference

https://api.crossref.org/works/10.1016/S0031-3955(16)34315-2

2 October 2023

Identifiers

0 references

1 reference